Live news related to IPSEN stock (FR0010259150): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
French pharmaceutical company Ipsen announced on Wednesday the acquisition of Swiss biotech firm Memo Therapeutics AG to bolster its rare disease port…
In early afternoon trading, the French biopharmaceutical company stands out in a sluggish Paris market. The stock continues its upward trend from rece…
The biopharmaceutical group Ipsen announced on Monday the acquisition of biotech firm Kartos Therapeutics for an initial amount of $450M. This move al…
The French biopharmaceutical company stands out sharply at mid-session in a downward trending Parisian market. The stock approaches its technical resi…
The French biopharmaceutical company is down in early afternoon trading in a declining Parisian market. The stock is erasing some of its recent reboun…
The biopharmaceutical company stands out at the week's close, moving against the downtrend of the Parisian market. The rebound comes after several ses…
The French biopharmaceutical company is slightly in the red in early afternoon trading, moving against a well-oriented CAC 40. The stock struggles to …
On Friday, the biopharmaceutical group Ipsen announced the launch of an employee savings plan aimed at further involving its employees in the company'…
The French laboratory Ipsen strengthens the clinical profile of Iqirvo, its second-line treatment for primary biliary cholangitis (PBC). The data anno…
This Wednesday morning, the biopharmaceutical laboratory shows a significant decline, going against the grain of a well-oriented Parisian market. The …
